Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03556332
Title A Study of Carfilzomib, Lenalidomide, Dexamethasone and Daratumumab for Patients With Relapsed/Refractory Myeloma With Salvage Autologous Hematopoietic Cell Transplantation
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama Comprehensive Cancer Center Birmingham Alabama 35294 United States Details
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge New Jersey 07920 United States Details
Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown New Jersey 07748 United States Details
Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale New Jersey 07645 United States Details
Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack New York 11725 United States Details
Memorial Sloan Kettering Westchester (Limited Protocol Activities) Harrison New York 10604 United States Details
Northwell Health Manhasset New York 11030 United States Details
New York University New York New York 10010 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Memorial Sloan Kettering Nassau (Limited Protocol Activities) Uniondale New York 11553 United States Details
Wake Forest University (Data Collection Only) Winston-Salem North Carolina 27109 United States Details
Medical College of Wisconsin (Data Collection Only) Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field